Andy Sassine insider trades
Andy Sassine has filed 26 Form 4s with the SEC that we hold, for ICAD (Director) and Arcturus Therapeutics Holdings Inc. (ARCT) (Chief Financial Officer, Director). Across all of them we count 1 purchase worth $20.5K and 13 sales worth $2.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 50,000 shares of Arcturus Therapeutics Holdings Inc. worth $1.6M, dated 2024-06-12. The first filing on our record is dated 2021-09-15 and the latest 2025-08-20.
ICAD
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-09-13 | S, sale reported on Form 4 | 10,000 | $110.9K | 2021-09-15 | SEC |
| 2021-09-14 | S, sale reported on Form 4 | 10,000 | $106.8K | 2021-09-15 | SEC |
| 2021-10-06 | S, sale reported on Form 4 | 10,000 | $105.6K | 2021-10-08 | SEC |
| 2021-10-07 | S, sale reported on Form 4 | 10,000 | $104.2K | 2021-10-08 | SEC |
| 2021-11-08 | S, sale reported on Form 4 | 10,000 | $108.9K | 2021-11-10 | SEC |
| 2021-11-09 | S, sale reported on Form 4 | 10,000 | $103.0K | 2021-11-10 | SEC |
| 2021-12-06 | S, sale reported on Form 4 | 10,000 | $67.1K | 2021-12-08 | SEC |
| 2021-12-07 | S, sale reported on Form 4 | 10,000 | $72.8K | 2021-12-08 | SEC |
| 2022-01-06 | S, sale reported on Form 4 | 10,000 | $62.0K | 2022-01-11 | SEC |
| 2022-01-07 | S, sale reported on Form 4 | 10,000 | $60.7K | 2022-01-11 | SEC |
| 2022-02-07 | S, sale reported on Form 4 | 10,000 | $52.6K | 2022-02-09 | SEC |
| 2022-02-08 | S, sale reported on Form 4 | 10,000 | $54.9K | 2022-02-09 | SEC |
Arcturus Therapeutics Holdings Inc. (ARCT)
Counted from the Form 4 filings this reporting owner (SEC CIK 1515322) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

